openPR Logo
Press release

Venous Stenosis Treatment Market 2032: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight | London Health Sciences Centre, Anesiva, Inc

08-05-2025 06:57 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Venous Stenosis Treatment Market

Venous Stenosis Treatment Market

(Albany, USA) DelveInsight's "Venous Stenosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Venous Stenosis, historical and forecasted epidemiology as well as the Venous Stenosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Venous Stenosis, offering comprehensive insights into the Venous Stenosis revenue trends, prevalence, and treatment landscape. The report delves into key Venous Stenosis statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Venous Stenosis therapies. Additionally, we cover the landscape of Venous Stenosis clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Venous Stenosis treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Venous Stenosis space.

To Know in detail about the Venous Stenosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Venous Stenosis Market Forecast - https://www.delveinsight.com/sample-request/venous-stenosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Venous Stenosis Market Report:
• The Venous Stenosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Key Venous Stenosis Companies: London Health Sciences Centre, Anesiva, Inc., and others
• Key Venous Stenosis Therapies: Sirolimus, CGT003 (E2F Duplex Decoy), and others
• The Venous Stenosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Venous Stenosis pipeline products will significantly revolutionize the Venous Stenosis market dynamics.
• Venous stenosis commonly occurs as a complication in patients undergoing hemodialysis, with prevalence rates reported between 20% to 50% in this population
• It frequently develops in veins used for vascular access in dialysis, such as the cephalic, basilic, and jugular veins
• The incidence of venous stenosis increases with the duration of dialysis treatment and repeated vascular access procedures
• Venous stenosis is also associated with deep vein thrombosis (DVT) and can occur after thrombotic events, leading to post-thrombotic syndrome
• The condition affects both upper and lower extremity veins, depending on the underlying cause or intervention site

Venous Stenosis Overview
Venous stenosis refers to the abnormal narrowing of a vein, which can restrict blood flow and lead to a variety of complications depending on the location and severity. This condition most commonly affects the central veins such as the subclavian, brachiocephalic, or iliac veins. It may result from external compression, inflammation, thrombosis, or as a long-term complication of central venous catheters, dialysis access, or pacemaker leads.

Clinically, venous stenosis can present with symptoms such as swelling, pain, and heaviness in the affected limb, particularly during physical activity. In cases involving dialysis patients, it may lead to access dysfunction and increased venous pressures during dialysis sessions. Chronic venous hypertension due to stenosis can result in skin changes, varicosities, and ulceration.

Diagnosis typically involves imaging modalities like Doppler ultrasound, venography, or cross-sectional imaging (CT or MR venography) to assess the location and degree of narrowing. Treatment depends on symptom severity and may include percutaneous transluminal angioplasty (PTA), stenting, or surgical bypass. In patients with dialysis access, early identification and management are crucial to maintain the longevity of the access site. Preventive strategies include minimizing catheter use and routine monitoring of vascular access in high-risk populations.

Get a Free sample for the Venous Stenosis Market Forecast, Size & Share Analysis Report: https://www.delveinsight.com/report-store/venous-stenosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Venous Stenosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Venous Stenosis Epidemiology Segmentation:
The Venous Stenosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Venous Stenosis
• Prevalent Cases of Venous Stenosis by severity
• Gender-specific Prevalence of Venous Stenosis
• Diagnosed Cases of Episodic and Chronic Venous Stenosis

Download the report to understand which factors are driving Venous Stenosis epidemiology trends @ Venous Stenosis Epidemiology Forecast - https://www.delveinsight.com/sample-request/venous-stenosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Venous Stenosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Venous Stenosis market or expected to get launched during the study period. The analysis covers Venous Stenosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Venous Stenosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Venous Stenosis Therapies and Key Companies
• Sirolimus: London Health Sciences Centre
• CGT003 (E2F Duplex Decoy): Anesiva, Inc.

Discover more about therapies set to grab major Venous Stenosis market share @ Venous Stenosis Treatment Landscape - https://www.delveinsight.com/sample-request/venous-stenosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Venous Stenosis Market Drivers
• Increasing Prevalence of Chronic Kidney Disease (CKD)
• Rising Incidence of Cardiovascular Disorders
• Advancements in Diagnostic and Interventional Technologies
• Growing Awareness and Early Diagnosis
• Expansion of Healthcare Infrastructure
• Aging Population

Venous Stenosis Market Barriers
• High Treatment Costs
• Lack of Awareness in Developing Regions
• Risk of Procedure-related Complications
• Limited Reimbursement and Insurance Coverage
• Shortage of Skilled Specialists

Scope of the Venous Stenosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Venous Stenosis Companies: London Health Sciences Centre, Anesiva, Inc., and others
• Key Venous Stenosis Therapies: Sirolimus, CGT003 (E2F Duplex Decoy), and others
• Venous Stenosis Therapeutic Assessment: Venous Stenosis current marketed and Venous Stenosis emerging therapies
• Venous Stenosis Market Dynamics: Venous Stenosis market drivers and Venous Stenosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Venous Stenosis Unmet Needs, KOL's views, Analyst's views, Venous Stenosis Market Access and Reimbursement

To know more about Venous Stenosis companies working in the treatment market, visit @ Venous Stenosis Clinical Trials and Therapeutic Assessment - https://www.delveinsight.com/sample-request/venous-stenosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Venous Stenosis Market Report Introduction
2. Executive Summary for Venous Stenosis
3. SWOT analysis of Venous Stenosis
4. Venous Stenosis Patient Share (%) Overview at a Glance
5. Venous Stenosis Market Overview at a Glance
6. Venous Stenosis Disease Background and Overview
7. Venous Stenosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Venous Stenosis
9. Venous Stenosis Current Treatment and Medical Practices
10. Venous Stenosis Unmet Needs
11. Venous Stenosis Emerging Therapies
12. Venous Stenosis Market Outlook
13. Country-Wise Venous Stenosis Market Analysis (2019-2032)
14. Venous Stenosis Market Access and Reimbursement of Therapies
15. Venous Stenosis Market Drivers
16. Venous Stenosis Market Barriers
17. Venous Stenosis Appendix
18. Venous Stenosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
• Angina Pectoris Market: https://www.delveinsight.com/report-store/angina-angina-pectoris-market
• Anorectal Malformation Market: https://www.delveinsight.com/report-store/anorectal-malformation-market
• Anovulation Market: https://www.delveinsight.com/report-store/anovulation-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-epidemiology-forecast
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Antiphospholipid Syndrome Aps Market: https://www.delveinsight.com/report-store/antiphospholipid-syndrome-aps-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Aspergillosis Market: https://www.delveinsight.com/report-store/aspergillosis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
• Bacterial Pyogenic Meningitis Market: https://www.delveinsight.com/report-store/bacterial-pyogenic-meningitis-market
• Becker Muscular Dystrophy Market: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/bile-duct-cancer-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/bradycardia-treatment-devices-market
• Bronchopulmonary Dysplasia Market: https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
• Bunion Market: https://www.delveinsight.com/report-store/bunion-market
• Cancer Anorexia Market: https://www.delveinsight.com/report-store/cancer-anorexia-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-crbsi-market-size-analysis

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Stenosis Treatment Market 2032: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight | London Health Sciences Centre, Anesiva, Inc here

News-ID: 4134078 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Venous

States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%. Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period. Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size? Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period. The current outlook for the venous catheter market is positive, driven by factors such as
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism. Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188 Pulmonary embolism occurs in almost one-third of patients